Cali Biosciences Initiates Phase 2b Study of Long-Acting Ropivacaine for Non-Opioid Treatment of Post-Operative Pain
SAN DIEGO, August 12, 2021 /PRNewswire/ — Cali Biosciences Co., Ltd. (hereinafter referred to as “CaliBio”), a global biopharmaceutical company focused on the research and...